Synonym
BW 175; BW-175; BW175;
IUPAC/Chemical Name
(2S)-N-(1-cyclohexyl-3,4-dihydroxy-5-morpholinopentyl)-2-(3-(ethylsulfonyl)-2-(naphthalen-1-ylmethyl)propanamido)hexanamide
InChi Key
KWZQSSZGRAYHPC-JVYWTFSOSA-N
InChi Code
InChI=1S/C37H57N3O7S/c1-3-5-18-32(38-36(43)30(26-48(45,46)4-2)23-29-16-11-15-27-12-9-10-17-31(27)29)37(44)39-33(28-13-7-6-8-14-28)24-34(41)35(42)25-40-19-21-47-22-20-40/h9-12,15-17,28,30,32-35,41-42H,3-8,13-14,18-26H2,1-2H3,(H,38,43)(H,39,44)/t30?,32-,33?,34?,35?/m0/s1
SMILES Code
OC(C(O)CC(NC([C@H](CCCC)NC(C(CC1=C2C=CC=CC2=CC=C1)CS(=O)(CC)=O)=O)=O)C3CCCCC3)CN4CCOCC4
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
687.93
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Silva GM, Poore MH, Ranches J, Santos GS, Moriel P. Effects of gradual reduction in frequency of energy supplementation on growth and immunity of beef steers. J Anim Sci. 2018 Feb 15;96(1):273-283. doi: 10.1093/jas/skx047. PubMed PMID: 29385600.
2: Capuco AV, Smith JJ, Waldo DR, Rexroad CE Jr. Influence of prepubertal dietary regimen on mammary growth of Holstein heifers. J Dairy Sci. 1995 Dec;78(12):2709-25. PubMed PMID: 8675754.
3: Atsuumi S, Funabashi H, Nakano M, Koike Y, Tanaka S, Harada J, Matsuyama K, Ikenaga T, Morishima H. Renin inhibitors. III. Synthesis and structure-activity relationships of transition-state inhibitors containing dihydroxyethylene isostere at the P1-P1 site. Chem Pharm Bull (Tokyo). 1994 Feb;42(2):306-13. Erratum in: Chem Pharm Bull (Tokyo) 1994 Jun;42(6):1379. PubMed PMID: 8149456.
4: Morishima H, Koike Y, Nakano M, Atsuumi S, Tanaka S, Funabashi H, Hashimoto J, Sawasaki Y, Mino N, Nakano M, et al. A novel nonpeptidic, orally active renin inhibitor. Biochem Biophys Res Commun. 1989 Mar 31;159(3):999-1005. PubMed PMID: 2495004.
